Print PDF

Bio-Tech and Life Sciences Experience

General Bio-Tech and Life Sciences Experience

  • Represented TGen in connection with its investment in, and licensing of technology to, the Molecular Profiling Institute. We also represent this client and its affiliates on an ongoing basis in a wide variety of other transactions as well as corporate governance matters.
  • Represented TD2, a growing drug development company affiliated with TGen, in the formation of the Pancreatic Cancer Research Team, a collaborative research alliance, led by TD2 and comprised of prominent national and international healthcare and scientific research organizations.
  • Ongoing representation of Mission3, a software company developing solutions to simplify and streamline the FDA clinical trial and product approval process for pharmaceutical and biotech companies.
  • Represented Mytogen, Inc. in connection with its formation, private equity offering and acquisition of assets from GenVec, Inc. relating to cardiac myoblast cell therapy research and related Phase I clinical trials.
  • Working with a start-up company specializing in conducting Phase I clinical trials in connection with a financing and purchase option agreement with a prominent international company.
  • Represented a major university in negotiating a multi-year funding agreement with a nonprofit biotechnology research organization and related technology licenses.
Jump to Page

How Can We
Help You?

By using this site, you agree to our updated Privacy Policy and our Terms of Use.